'Viele of this Patienten Haben Krebs und If you sterben, nehmen In sterben Menschen ein, percent ' with lupus develop the disease after taking rituximab and other immunosuppressive treatments. In 2008, Bennett said, the manufacturer of the drug, Genentech and Biogen Idec, letters to doctors warning that a patient with rheumatoid arthritis who had been taking rituximab also died from the brain infection. The companies asked if doctors had the disease in cancer patients taking the drug were detected.
One of the other two drugs, Raptiva has been taken off the market in April this year, because of the risk of PML. The other drug, Tysabri , was removed from the market for 1? Year because similar concerns.In the University of Ulster on a new procedure for coating stents working of the medical devices are used prevent open arteries and veins that they keeping blocking up.
The team with professors of Jim McLaughlin, John Anderson and Paul Maguire are based to the Northern Ireland Bio - Engineering Centre at the University of Jordanstown campus.